SO
PLX icon

STRS Ohio’s Protalix BioTherapeutics PLX Stock Holding History

STRS Ohio’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$690K Buy
+296,100
New +$627K ﹤0.01% 967

Other funds holding PLX

B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HIM
Harbour Investment Management Edmonds, Washington $194M AUM 15.93% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
OGF
Orin Green Financial San Diego, California $271M AUM 20.78% 1-Year Est. Return

STRS Ohio's PLX Position: Q2 2026 in Review

STRS Ohio opened a new position in Protalix BioTherapeutics (PLX) in Q2 2026: 296,100 shares worth $690K. The stake represents ﹤0.01% of the portfolio and ranks #967 among its holdings.

22 funds tracked by Wall St. Rank hold PLX as of Q2 2026.

  • STRS Ohio held 296,100 shares of Protalix BioTherapeutics worth $690K as of Q2 2026.
  • Protalix BioTherapeutics was a new STRS Ohio position in Q2 2026.
  • Protalix BioTherapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #967 holding.
  • 22 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.